At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected
Only in the crazy sector of metabolic medicines can 32% revenue growth be considered a disappointment. That’s how much Eli ...
Friday, March 14, 2025
Tag: Eli
Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix, Hershey and more
Check out the companies making headlines in midday trading: Paramount Global — The media conglomerate's stock dropped more than 5% ...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. Mike ...
Eli Lilly Fatty Liver Drug Posts Promising Early Data, But Field Is Still Competitive
Eli Lilly metabolic disorder medication tirzepatide, already approved in type 2 diabetes and weight management, now has early clinical data ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.